• Policy & Insight

How we helped shape Scotland’s cancer referral guidelines

We just helped bring Scotland’s cancer referral guidelines in line with the latest evidence, and we want to make sure the rest of the UK is up to date, too. We just helped bring Scotland’s cancer referral guidelines in line with the latest evidence, and we want to make sure the rest of the UK is up to date, too.

11 August 2025

• For Researchers

Is there a ribosomal weakness in cancer?

Once thought too conserved to be a therapeutic target for cancer, new insights could reveal ribosomal biogenesis to be an Achilles heel... Once thought too conserved to be a therapeutic target for cancer, new insights could reveal ribosomal biogenesis to be an Achilles heel...

9 July 2025

• Policy & Insight

Making a mark: looking back at three years of Smokefree UK

To celebrate the past three years of our Smokefree UK campaign, we’re looking back at three moments where our campaigning has made a mark. To celebrate the past three years of our Smokefree UK campaign, we’re looking back at three moments where our campaigning has made a mark.

4 July 2025

• Policy & Insight

Navigating the innovation roadmap: from discovery to patient impact

For a discovery or idea to help people affected by cancer, it must travel the innovation roadmap. We're working to make the journey smoother. For a discovery or idea to help people affected by cancer, it must travel the innovation roadmap. We're working to make the journey smoother.

17 June 2025

• For Researchers

Understanding CAFs to improve radiotherapy outcomes

We really need to further unpick the complexity of cancer-associated fibroblasts if we want to improve radiotherapy outcomes says Anna Wilkins We really need to further unpick the complexity of cancer-associated fibroblasts if we want to improve radiotherapy outcomes says Anna Wilkins

16 June 2025

• For Researchers

The stellar mission taking on cellular plasticity in bowel cancer

Backed by £5.5m of funding from CRUK and its partners, the hugely ambitious CRC-STARS programme aims to revolutionise how bowel cancer is treated. Backed by £5.5m of funding from CRUK and its partners, the hugely ambitious CRC-STARS programme aims to revolutionise how bowel cancer is treated.

9 June 2025

• For Researchers

Skin deep: Rethinking liquid biopsy for skin cancer

In the search for skin cancer diagnostic biomarkers, one team are looking beyond blood to the interstitial fluid... In the search for skin cancer diagnostic biomarkers, one team are looking beyond blood to the interstitial fluid...

28 May 2025

• For Researchers

Beyond the genome: Harnessing the power of super-enhancers for blood cancer

The mysteries of the epiregulome need to be tackled head-on if we are to get new precision treatments for blood cancers The mysteries of the epiregulome need to be tackled head-on if we are to get new precision treatments for blood cancers

21 May 2025

• Science & Technology

The mysterious stem cells that could hold the key to beating bowel cancer

Researchers at UCL Cancer Institute are closing in on answers to one of bowel cancers' biggest challenges – why people’s cancers respond to treatment differently Researchers at UCL Cancer Institute are closing in on answers to one of bowel cancers' biggest challenges – why people’s cancers respond to treatment differently

9 May 2025